Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication
Clinical trial NCT04796584 · TERMINATED
Trial details
- NCT number
- NCT04796584
- Sponsor
- Providence Health & Services
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-11
- Primary completion
- 2022-10-04
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.